Dr. Ming-Hu Han Discovers Brain's Natural Resilience Mechanism

Dr. Han, a Johnson & Johnson / One Mind Institute Rising Star Award winner, and his team may have opened a door to a new class of antidepressants.

Problems are often best resolved by forging through them rather than pulling back. For example, psychotherapies such as CBT promote active coping mechanisms which work in this way. However, until now, it has not been known how the brain’s physiological stress resilience mechanism works. Evidently, while some people seem wired to be able to handle stress with resilience, a small percentage (about 5%) become severely depressed when faced with chronic stress. According to the theory guiding the research of Johnson & Johnson / One Mind Institute Rising Star award winner Dr. Ming-Hu Han, the key to this difference lies in how the brain’s reward system, specifically the network of dopamine neurons in the ventral tegmental area (VTA), reacts to stress. Might the brain’s natural resilience work like the antidepressant drug fluoxetine (Prozac), which reduces the excitation of these neurons? Or not? Using his Rising Star grant, Dr. Han and his lab set out to find out.

First, Han’s team classified their cohort of experimental mice into those susceptible to depressive behavior in response to repeated defeats in hostile social encounters (calling these “susceptible” mice), and those which continue to behave like unstressed control mice despite repeated social defeats (calling these “resilient” mice). After subjecting these susceptible and resilient mice to chronic stress, Han’s team measured the firing rate of the aforementioned VTA dopamine neurons in each group. In the susceptible group, they found these neurons to be firing more rapidly than in the control group, while in the resilient group, they found these neurons to be firing similarly to the control group. So far, an interesting insight was gained: stress makes susceptible mice’s dopamine neurons fire more rapidly in response to stress.

However, their next measurements revealed a surprise: while the excitatory (Ih) electrical current in the neurons of the susceptible mice was stronger than in the control mice, as expected based on the susceptible mice’s faster firing rate, in the resilient mice the current was stronger than in either of the other 2 groups! How to explain this counterintuitive discovery?

Han’s team investigated further: they then measured the inhibitory (K+) currents in the resilient mice’s VTA dopamine neurons and found them also to be significantly stronger than in either the susceptible or control mice.

Based on this finding, Han’s team hypothesized that in the resilient mice’s neurons, stress first induced a much stronger excitatory (Ih) current, which in turn induced a faster firing rate, which in turn triggered stronger inhibitory (K+) currents, which then slowed down the firing to a normal and very stable rate. The team explored further and was able to validate this hypothesis with genetic and optogenetic experiments. The team had discovered the mechanism by which the resilient brain, at least in these mice, self-regulated its reward circuit to maintain healthy behavior.

In this investigation, the team found that giving susceptible mice repeated doses of a mood stabilizing drug known to enhance the Ih current, lamotrigine, created changes in Ih, K+, and firing rate consistent with this resilience process. Moreover, after these lamotrigine doses, the susceptible mice behaved like resilient mice.

Could a new class of antidepressant drugs which mimic natural resilience mechanisms, helping the brain to “push through” stress rather than “pulling it back”, emerge from Dr. Han’s studies? He and his team hope so. “Overall,” they write, “our findings not only unravel a critical self-stabilizing capacity of midbrain dopamine neurons in the brain’s reward circuit, but also identify a conceptually different strategy of promoting natural resilience. This may provide useful information for the development of naturally acting antidepressants.”

Dr. Han and his team have just published these results in the prestigious journal Science. We at One Mind Institute are exceptionally proud to sponsor their research. We hope that their discoveries will soon bear fruit for the almost 15 million American adults and many more around the world who suffer from major depressive disorder.

If you would like to support such groundbreaking brain health research, please consider a tax-deductible donation to One Mind Institute.

"When I heard of the groundbreaking work the Staglins were doing through their organization One Mind Institute, such as research into preventing schizophrenia from ever occurring, I hoped to meet them. When I did I was amazed by their non-stop energy and complete devotion to the cause. But most of all, I was moved by their sincere desire to share ideas with people from all backgrounds and fields. As I continue to create films to inspire empathy for those with mental illness, I remain inspired by the Staglins and what One Mind Institute has done to transform mental health research and improve lives. "
"One Mind Institute has distinguished itself as a leader in the fight against brain disease. One Mind Institute’s vision of a world without mental illness seems beyond reach only to those who have not seen firsthand the intensity of One Mind Institute’s dedication and focus. These folks are not giving up until they’ve won. The Saks Institute is delighted to be One Mind Institute’s partner in the fight."
"One Mind Institute is an organization equal parts compassion and science. A critical component of their work is advocacy and voice for millions of people who live with mental illnesses. Equally important is the incredible efforts they provide to further research in learning more about the brain and identifying effective treatments for brain diseases. One Mind Institute is a leader in the field of mental illness!"
"As a family member of someone living with schizoaffective disorder, I am proud to support One Mind Institute’s profoundly important work. One Mind Institute allows those touched in some way by psychiatric illness to take action and work toward solutions by helping to spur early stage research. One Mind Institute’s audacious mission to find a cure for psychiatric illness in one generation is what it will take to make meaningful progress, and holds the promise of changing millions of lives around the globe. "
"One Mind Institute, thank you again for funding CAPPS/ABBRC. Our daughter, Anna, participated in the program 2012-2013 and just received her final assessment. While this research helps others, know how much we appreciated participating with such genuinely dedicated people (very well selected to work with adolescents). It was very helpful for us as well, and provides us with even more hope. We're so impressed with the program."
"Having struggled with schizophrenia since a young woman, I am deeply grateful for what One Mind Institute does. One Mind Institute’s unwavering commitment to support research is an inspiration to those of us who long for the day when a cure for serious mental illness is found. I think of One Mind Institute as a good friend and kindly mentor who has taken up my cause and fights for my mental health each and every day."
"From the moment I found One Mind Institute and met the amazing Staglin family I knew that my advocacy would grow by leaps and bounds. Through their dedication and commitment I found a community of brilliant scientists, passionate philanthropists, music lovers and a new mental health family to call my own. I cherish the work One Mind Institute does every day to advance the research on brain disorders, to increase the awareness around mental illness and mental health and to create a community of love and support for advocates everywhere. I would not be the person I am today without the inspiration One Mind Institute has provided me."
"The support of One Mind Institute has been absolutely essential to all of the psychosis prediction and prevention efforts of CAPPS and the NAPLS. On behalf of the patients and families who have received high quality clinical services in our program regardless of their ability to pay, and on behalf of the numerous dedicated members of our research and clinical treatment teams, I am so incredibly grateful for One Mind Institute’s generous contributions. On a personal note, it is very inspiring to see the huge gains made for mental health research and awareness over the past several years, which have been sparked in large part by the efforts of the Staglin family."

Stay Connected

Sign up and receive e-newsletters and more

One Mind Institute is a 501(c)3 nonprofit, Tax ID # 68-0359707